ABSTRACT
Rhei Radix et Rhizoma is a kind of traditional Chinese medicinal material in China, which has unique efficacy and rich resources. It is mainly distributed in the alpine mountains of temperate and subtropical Asia. Its genuine producing areas are Gansu Province, Qinghai Province, Sichuan Province, and Tibet Autonomous Region. In recent years, with the continuous in-depth study of Radix et Rhizoma by scholars at home and abroad, many kinds of chemical constituents, extensive pharmacological effects and application and development of Radix et Rhizoma have attracted much attention, and have broad application prospects and considerable market value. Based on the analysis of its chemical composition and traditional efficacy combined with modern pharmacological action, and according to the theory of quality marker, the quality markers of Radix et Rhizoma were predicted and analyzed from the aspects of the chemical composition and traditional medicinal properties, traditional efficacy, new clinical uses, plasma composition, measurable components, effective components in different compatibility, and the effect of storage time and so on, which provides a scientific basis for the quality evaluation of Radix et Rhizoma and establishment of its quality control system.